Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Fascin (FSCN1) (Middle Region) Peptid

FSCN1 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN8100488
168,15 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für Fascin (FSCN1) (Middle Region) Peptid (ABIN8100488)

Target

Fascin (FSCN1)

Spezies

Human

Quelle

  • 9
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Verwendungszweck

    FSCN1 Peptide - middle region

    Sequenz

    ANRSSYDVFQ LEFNDGAYNI KDSTGKYWTV GSDSAVTSSG DTPVDFFFEF
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Target

    Fascin (FSCN1)

    Hintergrund

    Background Information: This gene encodes a member of the fascin family of actin-binding proteins. Fascin proteins organize F-actin into parallel bundles, and are required for the formation of actin-based cellular protrusions. The encoded protein plays a critical role in cell migration, motility, adhesion and cellular interactions. Expression of this gene is known to be regulated by several microRNAs, and overexpression of this gene may play a role in the metastasis of multiple types of cancer by increasing cell motility. Expression of this gene is also a marker for Reed-Sternberg cells in Hodgkin's lymphoma. A pseudogene of this gene is located on the long arm of chromosome 15.

    Alternative Symbols: HSN, SNL, p55, FAN1

    Molekulargewicht

    55 kDa

    Gen-ID

    6624

    NCBI Accession

    NP_003079

    UniProt

    Q16658
Sie sind hier:
Chat with us!